Stay updated on Eribulin + Pembrolizumab in Soft Tissue Sarcomas Clinical Trial

Sign up to get notified when there's something new on the Eribulin + Pembrolizumab in Soft Tissue Sarcomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Eribulin + Pembrolizumab in Soft Tissue Sarcomas Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The clinical trial record for the Eribulin and Pembrolizumab study in soft tissue sarcomas is displayed, including eligibility criteria, study design, outcome measures, and posted results. The record indicates that the study is completed and is no longer recruiting participants.
    Difference
    59%
    Check dated 2026-11-10T20:10:05.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov study record page still displays a 403 Forbidden error. Its footer revision label changes from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-03T20:16:54.000Z thumbnail image
  3. Check
    26 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a terminology transition from “Artificial Intelligence” to “Super Intelligence,” and the footer revision label changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T20:45:54.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-06T19:54:51.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error instead of the study record, indicating access is denied to this entry. The page shows a minimal header, a 403 message, and a Home button.
    Difference
    20%
    Check dated 2026-09-22T23:15:47.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    A new revision tag v3.7.0 is now shown, replacing the previous v3.6.6, indicating an updated version of the page content.
    Difference
    0.1%
    Check dated 2026-09-15T21:56:44.000Z thumbnail image

Stay in the know with updates to Eribulin + Pembrolizumab in Soft Tissue Sarcomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Eribulin + Pembrolizumab in Soft Tissue Sarcomas Clinical Trial page.